Story thread · 2 reports / 1 sources

Prediction: Eli Lilly’s Next Growth Wave Could Surprise Investors

247wallst.com · 2hShare

Eli Lilly is growing faster than any other mega-cap drugmaker, but a pipeline drug still awaiting approval and falling U.S. prices are pulling the stock in opposite directions. The outcome of that tension shapes whether shares have another 20% to climb or stall near today's levels.

First report: Eli Lilly Wavered Over the Last Month: One of Wall Street’s Biggest Banks Says 35% Gains Still to Come — 247wallst.com, 1d